Herpetic Stomatitis Symptoms & Treatment

Herpetic Stomatitis Symptoms & Treatment

Iontophoresis can be used as a method of treating herpes simplex virus and aphthous gingivostomatis. The lesions progressed despite treatment with intravenous acyclovir and vidarabine. Stomatitis can occur at any point in a person’s life but is seen more often in children and adolescents. Clinical examination and viral culture were repeated every 2 to 3 days as long as symptoms or signs persisted. In contrast, the fully glycosylated gC was not sensitive to endo H treatment. Approximately 90% of the population carries herpes simplex virus. Two different dosing strategies exist: 5 mg/kg once a week [13, 7, 8, 10, 11] and 1 mg/kg 3 times a week [46, 9].

Herpetic Stomatitis Symptoms & Treatment
36 days; P = .001). These data suggest that macrophages may acquire resistance to infection by VSV and HSV-1 after treatment with cAMP inducers. This is an emergency and can lead to blindness. Dehydration may develop if the child refuses to eat and drink enough because of a sore mouth. Children should strictly avoid close contact with people who have cold sores (for example, no kissing parents who have active cold sores). Children should also avoid other children with herpetic stomatitis. They should not share utensils, glasses, or food with actively infected people.

The condition can occur as a single sore or they can appear in clusters. Head and neck. In: Kumar V, Abbas AK, Fausto N, Aster JC, eds. Dehydration may develop if the child refuses to eat and drink enough because of a sore mouth. Because the patient had a history of moderate pancytopenia secondary to either GVHD or medications and to avoid additional myelosuppression associated with ganciclovir therapy, cidofovir was started (5 mg/kg once a week, given with probenecid), and prophylactic acyclovir was discontinued (Figure 1A). Philadelphia, Pa: Saunders Elsevier; 2009:chap 16. Review Date: 8/2/2011 Reviewed By: Neil K.

Kaneshiro, MD, MHA, Clinical Assistant Professor of Pediatrics, University of Washington School of Medicine. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

You may also like